Correction to: Nature https://doi.org/10.1038/nature25015, published online 16 November 2017.
In the gel source data for Extended Data Fig. 2b (page 7 of Supplementary Fig. 1 of the Letter) of this Letter, the label “IB: Cyclin A” should read “IB: Cyclin E”. Figure 1 of this Amendment shows the original, correct Extended Data Fig. 2b and its corrected Source Data. The original Letter has not been corrected.
Author information
Authors and Affiliations
Corresponding authors
Additional information
These authors jointly supervised: Gordon J. Freeman, Piotr Sicinski, Wenyi Wei
Rights and permissions
About this article
Cite this article
Zhang, J., Bu, X., Wang, H. et al. Author Correction: Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance. Nature 571, E10 (2019). https://doi.org/10.1038/s41586-019-1351-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-019-1351-8
This article is cited by
-
TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
Cell Communication and Signaling (2024)
-
Targeting ATR in patients with cancer
Nature Reviews Clinical Oncology (2024)
-
Tumor stem cell-derived exosomal microRNA-17-5p inhibits anti-tumor immunity in colorectal cancer via targeting SPOP and overexpressing PD-L1
Cell Death Discovery (2022)
-
Influence of direct electric field on PMCG-alginate-based microcapsule
Emergent Materials (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.